Publications | COVID-19

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Gendered Experiences of COVID-19 Vaccination in Freetown: A Qualitative Study in Portee-Rokupa Community.

Conteh, A; Sesay, IJ; Macarthy, J; Koroma, B; Priddy, C; ENRIA, L;

2023

(2023).

Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.

Allen, H; Tessier, E; Turner, C; Anderson, C; Blomquist, P; SIMONS, D; Løchen, A; JARVIS, CI; Groves, N; Capelastegui, F; Flannagan, J; Zaidi, A; Chen, C; Rawlinson, C; Hughes, GJ; Chudasama, D; Nash, S; Thelwall, S; Lopez-Bernal, J; Dabrera, G; Charlett, A; Kall, M; Lamagni, T;

2023

Epidemiology and infection, (2023).151, 10.1017/S0950268823000420.

Students' and staffs' views and experiences of asymptomatic testing on a university campus during the COVID-19 pandemic in Scotland: a mixed methods study.

Bauld, L; Street, A; Connelly, R; Bevan, I; Morlet Corti, Y; Baxter, MS; STAGG, HR; Christison, S; Mulherin, T; Sinclair, L; Aitman, T;

2023

BMJ open, (2023).13 3 10.1136/bmjopen-2022-065021.

Patient and public involvement within epidemiological studies of long COVID in the UK.

Routen, A; O'Mahoney, L; Aiyegbusi, OL; Alder, Y; Banerjee, A; Buckland, L; Brightling, C; Calvert, M; Camaradou, J; Chaturvedi, N; Chong, A; Dalrymple, E; EGGO, RM; Elliott, P; Evans, RA; Gibson, A; Haroon, S; HERRETT, E; Houchen-Wolloff, L; Hughes, SE; Jeyes, F; Matthews, K; McMullan, C; Morley, J; Shafran, R; ... Khunti, K.

2023

Nature medicine, (2023).29 4 10.1038/s41591-023-02251-5.

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.

Goswami, H; Alsumali, A; Jiang, Y; Schindler, M; Duke, ER; Cohen, J; BRIGGS, A; Puenpatom, A;

2023

PharmacoEconomics, (2023).41 5 10.1007/s40273-023-01263-w.

Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study.

PUNG, R; Clapham, HE; Russell, TW; CMMID COVID-19 Working Group,; Lee, VJ; KUCHARSKI, AJ;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02802-0.

Shielding individuals at high risk of COVID-19: a micro-simulation study. Model and analyses.

VAN ZANDVOORT, K; CHECCHI, F;

2023

, Github (2023).

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.

SERWANGA, J; Ankunda, V; Sembera, J; Kato, L; Oluka, GK; Baine, C; Odoch, G; Kayiwa, J; Auma, BO; Jjuuko, M; Nsereko, C; Cotten, M; Onyachi, N; Muwanga, M; Lutalo, T; Fox, J; Musenero, M; KALEEBU, P; COVID-19 Immunoprofiling Team,;

2023

Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1152522.

SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.

Parker, E; Thomas, J; Roper, KJ; Ijaz, S; EDWARDS, T; Marchesin, F; Katsanovskaja, K; Lett, L; Jones, C; Hardwick, HE; Davis, C; Vink, E; McDonald, SE; Moore, SC; Dicks, S; Jegatheesan, K; Cook, NJ; Hope, J; Cherepanov, P; McClure, MO; Baillie, JK; Openshaw, PJ M; Turtle, L; Ho, A; Semple, MG; ... ISARIC4C Investigators,

2023

Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1146702.

Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults.

Thomas, AC; Oliver, E; Baum, HE; Gupta, K; Shelley, KL; Long, AE; Jones, HE; Smith, J; Hitchings, B; Di Bartolo, N; Vasileiou, K; Rabi, F; Alamir, H; Eghleilib, M; Francis, O; Oliver, J; Morales-Aza, B; Obst, U; Shattock, D; Barr, R; Collingwood, L; Duale, K; Grace, N; Livera, GG; Bishop, L; ... CoMMinS Study Team,

2023

Communications medicine, (2023).3 1 10.1038/s43856-023-00264-2.